Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Millipore Corp. Q2 2009 Earnings Call Transcript
- Question-and-Answer SessionOperator Operator Instructions. Our first question is from the line of Jon Wood with Bank of America. Please go ahead. Jon Wood - Bank of America Martin, you increased your currency revenue guidance by about a 1.5. Can you give us a sense of what proportion of that...
- Earnings calls 2009-08-06
Additional Resources
- PURE Bioscience Begins Trading on NASDAQ
- Symbol Remains "PURE" SAN DIEGO -- Effective with the opening of the market today, shares of PURE Bioscience (NASDAQ: PURE) are now trading on the NASDAQ Stock Market. PURE Bioscience's stock most recently traded on the Over-the-Counter Bulletin Board. The trading symbol remains "PURE." The move was previously disclosed...
- Research articles 2008-04-02
- Bioscience bottleneck; With coveted University Circle lab space at a premium, startups are finding they have no place to go.(PrognostiX)
- Byline: SHANNON PETTYPIECE When a new employee at Cleveland bioscience company PrognostiX showed up last week for his first day at the Cleveland Clinic's bioscience incubator, the company found it had no place to put him. That's because Prognost Byline: SHANNON...
- Research articles 2005-04-25
- ALZA Corp. to purchase 4.9% of U.S. Bioscience Inc
- WEST CONSHOHOCKEN, Pa.--BUSINESS WIRE--Feb. 4, 1997--ALZA Corp. (NYSE: AZA) and U.S. Bioscience Inc. (AMEX:UBS) Tuesday announced that U.S. Bioscience will issue 1,178,882 common shares to ALZA (which will be 4.9% of the outstanding shares of U.S. Bioscience) at a purchase price of $18.256 per share for an aggregate investment of...
- Research articles 1997-02-04
- Oxford Partners, Matuschka form an international bioscience fund. (Matuschka Venture Partners; International Bioscience Fund-Japan)
- Oxford Partners, Matuschka form an international bioscience fund STAMFORD -- Oxford Partners and Matuschka Venture Partners have formed the International Bioscience Fund-Japan, a venture capital partnership that will invest in emerging growth companies. The program follows formation of the previously announced ...
- Research articles 1991-04-22
- Millipore Announces New Bioscience Division President
- BILLERICA, Mass. -- Millipore Corporation (NYSE:MIL), a life science leader that provides technologies, tools and services for bioscience research and biopharmaceutical manufacturing, today announced that Jon DiVincenzo has been appointed to succeed Dominique Baly as the President of its Bioscience Division. Mr. DiVincenzo, currently the Vice President, Global Sales and...
- Research articles 2008-06-12
- More Than 75 Bioscience Leaders to Attend Networking Reception December 6 at Virginia Tech
- RICHMOND, Va. -- The Virginia Biotechnology Association VaBIO, the premier state-wide trade organization for the bioscience industry, is hosting Blacksburg's bioscience community at "Biotech After Hours", a networking reception, on December 6, 2007 at the Virginia Bioinformatics Institute VBI at Virginia Tech. Pre-registration for the unique networking event has garnered...
- Research articles 2007-12-05
- PURE Bioscience to Present at Taglich Brothers 3rd Annual Small Cap Equity Conference
- SAN DIEGO -- PURE Bioscience (OTCBB:PURE), developer and marketer of patented ionic silver-based antimicrobial technology products in the bioscience sector, announced today that the Company's Chief Executive Officer, Michael L. Krall, will deliver a presentation on behalf of PURE Bioscience at the Taglich Brothers 3rd Annual Small Cap Equity Conference...
- Research articles 2006-04-25
- Abraxis Bioscience, Inc. Q1 2008 Earnings Call Transcript
- Earnings Call ExcerptAbraxis Bioscience, Inc. ABII Q1 2008 Earnings Call May 15, 2008 11:30 am ET Executives Daniel Saks – Vice President of Investor Relations and Corporate Communication Patrick Soon-Shiong, M.D. – Chairman and Chief Executive Officer Lisa Gopalakrishna – Chief Financial Officer Presentation Operator Good day ladies...
- Earnings calls 2008-05-15
- Eden Bioscience Regains Compliance With Nasdaq Minimum Bid Price Listing Requirement
- Eden Bioscience Corporation (NASDAQ: EDEN) today announced that it has received a letter from the Nasdaq Stock Market notifying it that the closing price per share of the Company's common stock was above the $1.00 minimum bid price for 10 consecutive trading days and that, as a result, the Company...
- Research articles 2005-01-18
- PURE Bioscience Reports Second Quarter Results; Accelerates Commercialization of Platform Technology
- SAN DIEGO -- PURE Bioscience (OTCBB:PURE), a developer and marketer of technology-based products in the bioscience and water treatment sectors, today reported revenues from continuing bioscience division operations of approximately $51,000 for the fiscal quarter ended January 31, 2005, compared with revenues of $54,800 in the same quarter last year....
- Research articles 2005-03-18
- PURE Bioscience Completes Sale of Water Treatment Division — Debt-Free, PURE Accelerates Sales and Development of Bioscience Products; Schedules Conference Call to Discuss Ongoing Bioscience Business Outlook
- SAN DIEGO -- PURE Bioscience (OTCBB:PURE) today announced it has completed the sale of its water treatment division to Maryland-based Innovative Medical Services, LLC for $2.375 million. At closing, PURE received $1.95M in cash. The Company will also receive two post-closing payments -- one in the amount of $225,000...
- Research articles 2005-06-01
- / CORRECTION - Eden Bioscience Corp.
- In the news release, "Eden Bioscience Corp. Announces Third Quarter Financial Results Release Date and Time," issued Friday, 10/21/2005, by Eden Bioscience Corporation (NASDAQ: EDEN), we are advised by the company that the first sentence of the first paragraph should read "Thursday, October 27, 2005" rather than "Tuesday, October 27,...
- Research articles 2005-10-24
- PURE Bioscience stock to continue on Nasdaq, Mykrolis introduce new purification media and Sionx announce new strategy.
- M2 PRESSWIRE-3 December 2003-World View Research: PURE Bioscience stock to continue on Nasdaq, Mykrolis introduce new purification media and Sionx announce new strategyC1994-2003 M2 COMMUNICATIONS LTD RDATE:12032003 City of Industry, CA -- PURE Bioscience (NASDAQ: PURE) today announced that its common...
- Research articles 2003-12-03
- Arizona Study Calls for Improved Bioscience Education Coordination, Training.
- By Ed Taylor, The Tribune, Mesa, Ariz. Knight Ridder/Tribune Business News Nov. 5--A study commissioned by the Maricopa Community Colleges is urging formation of a statewide Bioscience Industry-Education Council to coordinate development of training programs for Arizona's future bioscience workers. ...
- Research articles 2003-11-05
- Eden Bioscience Regains Compliance With Nasdaq Minimum Bid Price Listing Requirement
- Eden Bioscience Corporation (NASDAQ: EDEN) today announced that it has received a letter from the Nasdaq Stock Market notifying it that the closing bid price per share of the Company's common stock was above the $1.00 minimum bid price for 10 consecutive trading days and that, as a result, the...
- Research articles 2008-03-18
- In July, Lumera formed a subsidiary, Plexera Bioscience, to serve as the operations unit of its bioscience business
- In July, Lumera formed a subsidiary, Plexera Bioscience, to serve as the operations unit of its bioscience business. Board member Joseph Vallner will serve as chairman and CEO. Most recently, he was CEO of Capnia. Lumera also engaged Robert W. Baird & Co. to evaluate partnering and financing alternatives.
- Research articles 2007-09-30
- U.S. Bioscience receives award for achievements in technology
- WEST CONSHOHOCKEN, Pa.--BUSINESS WIRE--Oct. 30, 1995--U.S. Bioscience Inc. (AMEX:UBS) announced Monday that the company has received the annual Enterprise Award for Technology Transfer of the Year.This award was given in recognition of U.S. Bioscience's success in acquiring rights to products that make a significant impact on the management of patients...
- Research articles 1995-10-30
- Oxford Bioscience Partners General Partner To Keynote Great Midwest Venture Capital Conference — GMVCC — www.gmvcc.com
- Business Editors INDIANAPOLIS--BUSINESS WIRE--Nov. 9, 2001 A leading figure in bioscience and healthcare financing, Michael Lytton, will keynote the 2001 Great Midwest Venture Capital Conference (GMVCCTM). Lytton is a general partner of Oxford Bioscience Partners OBP, a life science venture capital firm that provides equity financing and...
- Research articles 2001-11-09
- State backs bioscience loans from Webster Bank. (Tech Cetera).
- When it comes to developing an attractive environment for bioscience companies, Connecticut seems to be putting its money where its mouth is. The state is launching a new program in January that will provide Connecticut banks with a 30 percent loan guarantee for small...
- Research articles 2002-10-07
- << Previous
- page 1 of 1
- Next >>
Presented by American Express